ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $402 | -74.6% | 126,812 | -49.6% | 0.03% | -82.7% |
Q4 2022 | $1,581 | -99.5% | 251,384 | +689.4% | 0.20% | +326.1% |
Q3 2022 | $344,000 | -74.6% | 31,846 | -78.6% | 0.05% | -74.7% |
Q1 2022 | $1,356,000 | -20.8% | 148,804 | +29.6% | 0.18% | -15.3% |
Q4 2021 | $1,713,000 | +370.6% | 114,815 | +723.0% | 0.22% | +424.4% |
Q2 2021 | $364,000 | +27.7% | 13,951 | +23.8% | 0.04% | -12.8% |
Q4 2020 | $285,000 | +3.3% | 11,273 | +6.1% | 0.05% | +46.9% |
Q4 2019 | $276,000 | – | 10,622 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |